Abstract
D&MD' s Expanding Opportunities in Contract Research and Contract Manufacture
of Biotherapeutics/ Biologics market analysis report is a comprehensive
compilation of CROs, CMOs and their numerous secondary interconnections. This
report traces the funding of the CRO network and highlights failure points
along the chain of the biologic' s production including the realization that
pharmaceutical productivity decline is most imminent in Phase II failure rates.
|